Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.
about
Oral vitamin D, still a viable treatment option for psoriasis.The role of vitamin D in psoriasis: a review.Resurgence of vitamin D: Old wine in new bottleVitamin D receptor gene polymorphisms and haplotypes (Apa I, Bsm I, Fok I, Taq I) in Turkish psoriasis patientsVitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going?Vitamin D deficiency in early life and the potential programming of cardiovascular disease in adulthood.Actions of 1 alpha,25-dihydroxyvitamin D3 on normal, psoriatic, and promoted epidermal keratinocytes.Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.Challenge and perspective: the relevance of ultraviolet (UV) radiation and the vitamin D endocrine system (VDES) for psoriasis and other inflammatory skin diseases.Skin: site of the synthesis of vitamin D and a target tissue for the active form, 1,25-dihydroxyvitamin D3.A study of ApaI and TaqI genotypes of the vitamin D receptor in Egyptian patients with psoriasis.Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes.Vitamin D3 inhibits proliferation and increases c-myc expression in fibroblasts from psoriatic patients.Treating psoriasis with calcipotriol.Points: 1,25 Dihydroxyvitamin D3 in psoriasis.Serum 25-hydroxyvitamin D levels in patients with skin diseases including psoriasis, infections, and atopic dermatitis.
P2860
Q34234791-FD29D067-732D-456C-B359-C5C9B0A095B8Q34458755-E4670E93-C194-4848-86DC-1DD48C41701AQ35806866-52245A13-F117-4F65-AECF-46314088035AQ36576962-72599CAE-A53C-4B9C-9BD0-0CEB43D9F834Q37959978-8717F6F2-DEEC-4216-BB8E-22E9E8E51715Q38110436-BCA55E6B-A998-4B56-ACAE-2324818DF197Q38202253-24450CDC-84E3-495C-8C1D-C5CF31D5056BQ38905499-0D3AF92C-B415-49B0-85CC-6A27482B045DQ39067901-B3C559F2-0AED-405E-AD12-DEC9795187B6Q39331877-22309B63-3BB5-4091-B3C6-F89C57790603Q39634170-10DFBE63-3704-45BB-B730-F38D2D18299FQ41762369-1F57252F-A7B2-4EC5-974E-494287003B87Q42463481-76047DAA-1BA5-4C60-851F-D7B236E1DB31Q42762694-7389AABC-D104-48E8-BB7A-8742F5EEAF98Q46153017-9D6D445E-B567-492C-9405-AEC3373A4A1DQ55229606-F94AA03F-0861-40B7-8089-D4662684C488
P2860
Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cultured psoriatic fibroblasts ...... y of 1,25-dihydroxyvitamin D3.
@en
Cultured psoriatic fibroblasts ...... y of 1,25-dihydroxyvitamin D3.
@nl
type
label
Cultured psoriatic fibroblasts ...... y of 1,25-dihydroxyvitamin D3.
@en
Cultured psoriatic fibroblasts ...... y of 1,25-dihydroxyvitamin D3.
@nl
prefLabel
Cultured psoriatic fibroblasts ...... y of 1,25-dihydroxyvitamin D3.
@en
Cultured psoriatic fibroblasts ...... y of 1,25-dihydroxyvitamin D3.
@nl
P2093
P2860
P356
P1476
Cultured psoriatic fibroblasts ...... y of 1,25-dihydroxyvitamin D3.
@en
P2093
P2860
P304
P356
10.1073/PNAS.82.16.5409
P407
P577
1985-08-01T00:00:00Z